At a glance
- Originator Biosearch Italia
- Class Antibacterials; Antifungals; Antiprotozoals
- Mechanism of Action Protein synthesis inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Bacterial infections; Protozoan infections; Vulvovaginal candidiasis
Most Recent Events
- 30 Sep 2005 Vicuron Pharmaceuticals has since been acquired by and merged into Pfizer
- 04 Aug 1998 No-Development-Reported for Bacterial infections in USA (Unknown route)
- 04 Aug 1998 No-Development-Reported for Protozoal infections in USA (Unknown route)